About that lived, observed, heard or read

Reflections on the biotechnology sector and around

About the reason for this blog

I want to put my findings, ideas and reflections on my experience in the biotechnology sector. My posts will be based both on my own and other's experience, on what I have read, heard or observed, and in any case my thoughts will always be personal opinions, fully subjective, which may or may not be shared by others in the industry. Of course, all my posts are not only open to comments, but I hope they can serve as a starting point for the debate.

Main menu

About filling the GAP

by evamb • marzo 28, 2014 • 0 Comments

This weekend I am flying to London to participate in the GAP Summit, which will take place in Cambridge next week. When I knew the initiative, just because of the name of the event and the topic to be developed,…

What is it about →

About making the rare general and personalize medicine

by evamb • febrero 25, 2014 • 0 Comments

At the moment, this post is only available in Spanish. Leave me a message if you would like to read it in English. Meanwhile, you can read it in this link and use Goggle Translator for getting an idea 😉

About the natural and evident

by evamb • febrero 5, 2014 • 0 Comments

At the moment this post is only available in Spanish. Leave me a message if you would like to read in English. Meanwhile, you can read it in this link and use Goggle Translator for getting an idea 😉

About transferring intangible assets

by evamb • enero 4, 2014 • 0 Comments

At the moment this post is only available in Spanish. Leave me a message if you would like to read in English. Meanwhile, you can read it in this link and use Goggle Translator for getting an idea 😉

About author’s rights (Part I)

by evamb • noviembre 8, 2013 • 0 Comments

At the moment this post is only available in Spanish. Leave me a message if you would like to read in English. Meanwhile, you can read it in this link and use Goggle Translator for getting an idea 😉

About what a patent is not

by evamb • octubre 17, 2013 • 0 Comments

At the moment this post is only available in Spanish. Leave me a message if you would like to read in English. Meanwhile, you can read it in this link and use Goggle Translator for getting an idea 😉

About the cost of a drug

by evamb • septiembre 17, 2013 • 0 Comments

At the moment this post is only available in Spanish. Leave me a message if you would like to read in English. Meanwhile, you can read it in this link and use Goggle Translator for getting an idea 😉

About patenting and “un-patenting”

by evamb • septiembre 1, 2013 • 0 Comments

At the moment this post is only available in Spanish. Leave me a message if you would like to read in English. Meanwhile, you can read it in this link and use Goggle Translator for getting an idea 😉

About the elevator to success

by evamb • agosto 15, 2013 • 0 Comments

At the moment this post is only available in Spanish. Leave me a message if you would like to read in English. Meanwhile, you can read it in this link and use Goggle Translator for getting an idea 😉

About the evolution leap

by evamb • julio 29, 2013 • 0 Comments

At the moment this post is only available in Spanish. Leave me a message if you would like to read in English. Meanwhile, you can read it in this link and use Goggle Translator for getting an idea 😉

Page 1 of 2
1 2 »
Ver el perfil de Eva Martin en LinkedInVer el perfil de Eva Martin

About what happens in Kinrel

About my book

About what happens in my Twitter account

Tweets por @EvaMartinBe

About my recent posts

  • About filling the GAP
  • About making the rare general and personalize medicine
  • About the natural and evident
  • About transferring intangible assets
  • About author’s rights (Part I)

What is it about?

antibodies biologics business angel cell therapy clinical research comercialization copyright CPE downpayment drugs elevator pitch entrepreneur first-in-human funders gene therapy GMP infraction intellectual property in vitro know-how licensing marketing Material Transfer Agreement medical food orphan drugs patents PCT personalized medicine pharma-biotech preclinical priority right public funds R&D rare diseases regulatory agencies results exploitation royalties spin-off spin-out strategy sufficiency of disclosure tech transfer toxicology unidad de invención university

Copyright © 2013-2019 About that lived, observed, heard or read. All Rights Reserved.